Drug successfully halts fibrosis in animal model of liver disease
Tuesday, August 7, 2012 - 13:00
in Health & Medicine
A potential new NADPH oxidase inhibitor therapy for liver fibrosis, a scarring process associated with chronic liver disease that can lead to loss of liver function.